• Subscribe
  • Magazine
  • Past Issues
  • Surveys
  • Industry Statistics
  • About Us
  • Members Only
  • Best Places to Work
    • Recent Quotes
    My Watchlist
    Indicators
    PennEnergy Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Predictive Oncology Inc (NQ: POAI )

    1.080 UNCHANGED
    Streaming Delayed Price Updated: 4:00 PM EDT, Jun 24, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 3,471
    Open 1.080
    Bid (Size) 1.080 (1)
    Ask (Size) 1.180 (1)
    Prev. Close 1.080
    Today's Range 1.080 - 1.080
    52wk Range 0.8940 - 7.120
    Shares Outstanding 4,063,081
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    InvestorNewsBreaks – Predictive Oncology Inc. (NASDAQ: POAI) Unveils Novel Technology, Eyes Significant Partnership Opportunities
    Via Investor Brand Network
    Topics Artificial Intelligence Intellectual Property
    Exposures Artificial Intelligence Intellectual Property
    Predictive Oncology Develops Novel Stem Cell Expression System for the Production of Functional and Stable G-Protein Coupled Receptors (GPCRs)
    From Predictive Oncology Inc.
    Via GlobeNewswire

    Performance

    YTD
    -69.36%
    -69.36%
    1 Month
    -48.20%
    -48.20%
    3 Month
    -58.62%
    -58.62%
    6 Month
    -67.27%
    -67.27%
    1 Year
    -76.11%
    -76.11%

    More News

    Read More
    InvestorNewsBreaks – Predictive Oncology Inc. (NASDAQ: POAI) Launches Novel Technology to Accelerate Cancer Drug Discovery, Development
    Via Investor Brand Network
    Topics Animal Testing Artificial Intelligence
    Exposures Animal Testing Artificial Intelligence
    Predictive Oncology Launches Novel 3D Cell Technology to Accelerate Cancer Therapeutic Drug Discovery
    From Predictive Oncology Inc.
    Via GlobeNewswire
    TinyGemsBreaks – Predictive Oncology Inc. (NASDAQ: POAI) CEO to Participate at Upcoming BIO International Convention 2024
    Via Investor Brand Network
    Topics Artificial Intelligence
    Exposures Artificial Intelligence
    Why Bank of Montreal Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
    Via Benzinga
    Why Ooma Shares Are Trading Higher By Around 17%; Here Are 20 Stocks Moving Premarket
    Via Benzinga
    Predictive Oncology Announces CEO Raymond Vennare to Present at the BIO International Convention 2024
    From Predictive Oncology Inc.
    Via GlobeNewswire
    12 Health Care Stocks Moving In Tuesday's Intraday Session
    Via Benzinga
    Why Applied DNA Sciences Shares Are Trading Lower By Around 68%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
    Via Benzinga
    Why Predictive Oncology (POAI) Stock Is Skyrocketing
    Via Benzinga
    TinyGemsBreaks – Predictive Oncology Inc. (NASDAQ: POAI) Announces Positive Results from Ovarian Cancer Study
    Via Investor Brand Network
    Topics Artificial Intelligence
    Exposures Artificial Intelligence
    12 Health Care Stocks Moving In Tuesday's Pre-Market Session
    Via Benzinga
    Predictive Oncology Announces Positive Results from Ovarian Cancer Study with UPMC Magee-Womens Hospital to be Presented at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
    From Predictive Oncology Inc.
    Via GlobeNewswire
    BioMedNewsBreaks — Predictive Oncology Inc. (NASDAQ: POAI) Announces Q1 2024 Financial Results, Provides Business Update
    Via Investor Brand Network
    Topics Artificial Intelligence
    Exposures Artificial Intelligence
    POAI Stock Earnings: Predictive Oncology Reported Results for Q1 2024
    Via InvestorPlace
    Predictive Oncology Reports First Quarter 2024 Financial Results and Provides Business Update
    From Predictive Oncology Inc.
    Via GlobeNewswire
    InvestorNewsBreaks – Predictive Oncology Inc. (NASDAQ: POAI) Schedules Release of Q1 2024 Financial Results, Conference Call
    Via Investor Brand Network
    Topics Artificial Intelligence
    Exposures Artificial Intelligence
    Predictive Oncology to Report First Quarter 2024 Financial Results on Wednesday, May 15, 2024
    From Predictive Oncology Inc.
    Via GlobeNewswire
    The 3 Most Undervalued AI Penny Stocks to Buy in May 2024
    Via InvestorPlace
    Topics Artificial Intelligence Economy
    Exposures Artificial Intelligence Economy
    AI-Fueled Penny Stocks: 3 High-Risk, High-Reward Opportunities
    Via InvestorPlace
    Topics Artificial Intelligence
    Exposures Artificial Intelligence
    12 Health Care Stocks Moving In Monday's After-Market Session
    Via Benzinga
    12 Health Care Stocks Moving In Monday's Pre-Market Session
    Via Benzinga
    Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
    Via InvestorPlace
    BioMedNewsBreaks — Predictive Oncology Inc. (NASDAQ: POAI) Partners with FluGen to Develop First-of-Its-Kind Intranasal Flu Vaccine for Global Distribution
    Via Investor Brand Network
    Topics Artificial Intelligence
    Exposures Artificial Intelligence
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.